{"disease":{"id":"arthropathy","name":"arthropathy"},"drugs":{"marketed":[{"drug_id":"abrilada","indication_name":"Psoriasis with arthropathy","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Abrilada","generic_name":"Adalimumab-Afzb","company_name":"AbbVie","drug_phase":"marketed","molecular_target":"Tumor necrosis factor-alpha (TNF-alpha)","drug_class":"TNF blocker","quality_score":10,"revenue":"10191","mechanism":"Adalimumab-afzb binds TNF-alpha and blocks interaction with p55 and p75 cell surface receptors."},{"drug_id":"ustekinumab","indication_name":"Psoriasis with arthropathy","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Stelara","generic_name":"ustekinumab","company_name":"Johnson & Johnson","drug_phase":"marketed","molecular_target":"p40 protein subunit of IL-12 and IL-23","drug_class":"","quality_score":63,"revenue":"9500","mechanism":"Ustekinumab binds to the p40 subunit of IL-12 and IL-23, disrupting their signaling and reducing inflammation."},{"drug_id":"chembl-chembl1201581","indication_name":"Psoriasis with arthropathy","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Remicade","generic_name":"INFLIXIMAB","company_name":"Johnson & Johnson","drug_phase":"marketed","molecular_target":"Tumor necrosis factor","drug_class":"Tumor Necrosis Factor Blocker [EPC]","quality_score":73,"revenue":"4200","mechanism":"Remicade works by binding to and neutralizing tumor necrosis factor, a protein that promotes inflammation and tissue damage."},{"drug_id":"etanercept","indication_name":"Psoriasis with arthropathy","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Enbrel","generic_name":"etanercept","company_name":"Immunex","drug_phase":"marketed","molecular_target":"Tumor necrosis factor","drug_class":"Tumor Necrosis Factor Blocker [EPC]","quality_score":77,"revenue":"3100","mechanism":"Enbrel works by binding to tumor necrosis factor, a protein that promotes inflammation, thereby reducing inflammation and alleviating symptoms."},{"drug_id":"apremilast","indication_name":"Psoriasis with arthropathy","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Otezla","generic_name":"APREMILAST","company_name":"Amgen","drug_phase":"marketed","molecular_target":"PDE4","drug_class":"Phosphodiesterase 4 Inhibitor [EPC]","quality_score":71,"revenue":"2100","mechanism":"Apremilast inhibits PDE4, increasing intracellular cAMP levels, but the exact therapeutic mechanism is unclear."},{"drug_id":"certolizumab-pegol","indication_name":"Psoriasis with arthropathy","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Cimzia","generic_name":"CERTOLIZUMAB PEGOL","company_name":"UCB","drug_phase":"marketed","molecular_target":"TNFα","drug_class":"Tumor Necrosis Factor Blocker [EPC]","quality_score":68,"revenue":"1600","mechanism":"Certolizumab pegol binds to and neutralizes human TNFα, reducing inflammation without causing antibody-dependent cell-mediated cytotoxicity."},{"drug_id":"betamethasone-acetate","indication_name":"Psoriasis with arthropathy","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Celestone Soluspan","generic_name":"BETAMETHASONE ACETATE","company_name":"","drug_phase":"marketed","molecular_target":"Glucocorticoid receptor","drug_class":"Corticosteroid","quality_score":42,"revenue":null,"mechanism":""},{"drug_id":"dexamethasone","indication_name":"Psoriasis with arthropathy","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Decadron","generic_name":"dexamethasone","company_name":"Generic (originally Merck)","drug_phase":"marketed","molecular_target":"Annexin A1, Interleukin-4, Androgen receptor","drug_class":"Corticosteroid [EPC]","quality_score":44,"revenue":null,"mechanism":""},{"drug_id":"adalimumab","indication_name":"Psoriasis with arthropathy","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Humira","generic_name":"ADALIMUMAB","company_name":"AbbVie","drug_phase":"marketed","molecular_target":"Tumor Necrosis Factor-alpha (TNF-alpha)","drug_class":"TNF blocker","quality_score":10,"revenue":null,"mechanism":"Adalimumab binds TNF-alpha and blocks interaction with p55 and p75 cell surface receptors."},{"drug_id":"infliximab","indication_name":"Psoriasis with arthropathy","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Remicade","generic_name":"infliximab","company_name":"Johnson & Johnson","drug_phase":"discontinued","molecular_target":"TNFα","drug_class":"Monoclonal antibody","quality_score":43,"revenue":null,"mechanism":"Infliximab binds to TNFα, blocking its interaction with receptors, reducing inflammation and immune responses."},{"drug_id":"remicade","indication_name":"Psoriasis with arthropathy","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Remicade","company_name":"Shanghai Biomabs Pharmaceutical Co., Ltd.","drug_phase":"marketed","molecular_target":"Tumor necrosis factor","drug_class":"","quality_score":16,"revenue":null,"mechanism":null},{"drug_id":"prednison","indication_name":"Psoriasis with arthropathy","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"prednison","company_name":"Wen Zhang","drug_phase":"marketed","molecular_target":"Annexin A1, Sodium/nucleoside cotransporter 1, Glucocorticoid receptor","drug_class":"","quality_score":19,"revenue":null,"mechanism":null},{"drug_id":"inflectra","indication_name":"Psoriasis with arthropathy","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Remicade","generic_name":"Infliximab-Dyyb","company_name":"Johnson & Johnson","drug_phase":"marketed","molecular_target":"Tumor Necrosis Factor alpha (TNFα)","drug_class":"TNF blocker","quality_score":10,"revenue":null,"mechanism":"Infliximab-dyyb neutralizes TNFα by binding with high affinity to soluble and transmembrane forms, inhibiting receptor binding."},{"drug_id":"adalimumab-adbm","indication_name":"Psoriasis with arthropathy","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"CYLTEZO","generic_name":"ADALIMUMAB-ADBM","company_name":"BOEHRINGER INGELHEIM","drug_phase":"marketed","molecular_target":"Tumor necrosis factor","drug_class":"","quality_score":24,"revenue":null,"mechanism":""},{"drug_id":"infliximab-qbtx","indication_name":"Psoriasis with arthropathy","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"IXIFI","generic_name":"INFLIXIMAB-QBTX","company_name":"PFIZER INC","drug_phase":"marketed","molecular_target":"Tumor necrosis factor","drug_class":"","quality_score":20,"revenue":null,"mechanism":""},{"drug_id":"methylprednisolone","indication_name":"Psoriasis with arthropathy","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Medrol","generic_name":"methylprednisolone","company_name":"Generic (originally Upjohn/Pfizer)","drug_phase":"marketed","molecular_target":"Annexin A1, Short transient receptor potential channel 5, Glucocorticoid receptor","drug_class":"Glucocorticoid (corticosteroid)","quality_score":62,"revenue":null,"mechanism":"Potent synthetic glucocorticoid with 5x hydrocortisone potency and minimal mineralocorticoid activity, used for severe inflammatory conditions."},{"drug_id":"hydrocortisone","indication_name":"Psoriasis with arthropathy","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Cortef","generic_name":"hydrocortisone","company_name":"Generic (originally Merck/Upjohn)","drug_phase":"marketed","molecular_target":"Annexin A1, Corticosteroid-binding globulin, Nitric oxide synthase, inducible","drug_class":"Corticosteroid [EPC]","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"triamcinolone","indication_name":"Psoriasis with arthropathy","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Rodinolone","generic_name":"TRIAMCINOLONE","company_name":"","drug_phase":"marketed","molecular_target":"Glucocorticoid receptor","drug_class":"Corticosteroid","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"prednisone","indication_name":"Psoriasis with arthropathy","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Deltasone","generic_name":"prednisone","company_name":"Generic (originally Schering)","drug_phase":"marketed","molecular_target":"Annexin A1, Sodium/nucleoside cotransporter 1, Glucocorticoid receptor","drug_class":"Corticosteroid [EPC]","quality_score":40,"revenue":null,"mechanism":""},{"drug_id":"golimumab","indication_name":"Psoriasis with arthropathy","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Simponi","generic_name":"GOLIMUMAB","company_name":"Centocor Ortho Biotech Inc","drug_phase":"marketed","molecular_target":"Tumor necrosis factor","drug_class":"Tumor Necrosis Factor Blocker [EPC]","quality_score":60,"revenue":null,"mechanism":"Simponi works by binding to tumor necrosis factor, preventing it from interacting with its receptors and thereby reducing inflammation."},{"drug_id":"betamethasone","indication_name":"Psoriasis with arthropathy","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Betametasone","generic_name":"BETAMETHASONE","company_name":"","drug_phase":"marketed","molecular_target":"Glucocorticoid receptor","drug_class":"Corticosteroid","quality_score":65,"revenue":null,"mechanism":"Betamethasone works by binding to the glucocorticoid receptor, which then triggers a series of downstream effects that reduce inflammation and suppress the immune system."},{"drug_id":"cortisol","indication_name":"Psoriasis with arthropathy","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Cortisol","company_name":"University of Zurich","drug_phase":"marketed","molecular_target":"Annexin A1, Corticosteroid-binding globulin, Nitric oxide synthase, inducible","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"prednisolone","indication_name":"Psoriasis with arthropathy","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Prelone","generic_name":"prednisolone","company_name":"Generic (originally Schering)","drug_phase":"marketed","molecular_target":"Annexin A1, Corticosteroid-binding globulin, G-protein coupled bile acid receptor 1","drug_class":"Glucocorticoid (corticosteroid)","quality_score":40,"revenue":null,"mechanism":""},{"drug_id":"cimzia","indication_name":"Psoriasis with arthropathy","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Cimzia","company_name":"University of Washington","drug_phase":"marketed","molecular_target":"Tumor necrosis factor","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"simponi","indication_name":"Psoriasis with arthropathy","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Simponi","company_name":"Alvotech Swiss AG","drug_phase":"marketed","molecular_target":"Tumor necrosis factor","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"prednisolon","indication_name":"Psoriasis with arthropathy","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"prednisolon","company_name":"Hannover Medical School","drug_phase":"marketed","molecular_target":"Annexin A1, Corticosteroid-binding globulin, G-protein coupled bile acid receptor 1","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"humira","indication_name":"Psoriasis with arthropathy","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Humira","company_name":"Sohag University","drug_phase":"marketed","molecular_target":"Tumor necrosis factor","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"methylprednisolon","indication_name":"Psoriasis with arthropathy","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Methylprednisolon","company_name":"Leiden University Medical Center","drug_phase":"marketed","molecular_target":"Annexin A1, Short transient receptor potential channel 5, Glucocorticoid receptor","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"stelara","indication_name":"Psoriasis with arthropathy","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Stelara","company_name":"Biocon Biologics UK Ltd","drug_phase":"marketed","molecular_target":"Interleukin-12, Interleukin-23","drug_class":"","quality_score":30,"revenue":null,"mechanism":"Stelara binds to the p40 subunit of IL-12 and IL-23, reducing inflammation in autoimmune diseases."},{"drug_id":"enbrel","indication_name":"Psoriasis with arthropathy","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Enbrel","company_name":"LG Life Sciences","drug_phase":"marketed","molecular_target":"Tumor necrosis factor","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"hydrocortisone-succinate","indication_name":"Psoriasis with arthropathy","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Solu-Cortef","generic_name":"hydrocortisone succinate","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Glucocorticoid receptor","drug_class":"Corticosteroid","quality_score":42,"revenue":null,"mechanism":""},{"drug_id":"hydrocortisone-acetate","indication_name":"Psoriasis with arthropathy","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Cortifoam","generic_name":"HYDROCORTISONE ACETATE","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Corticosteroid-binding globulin","drug_class":"Corticosteroid","quality_score":42,"revenue":null,"mechanism":""},{"drug_id":"leflunomide","indication_name":"Psoriasis with arthropathy","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Arava","generic_name":"LEFLUNOMIDE","company_name":"Sanofi","drug_phase":"marketed","molecular_target":"Cytochrome P450 1A2","drug_class":"Antirheumatic Agent [EPC]","quality_score":80,"revenue":null,"mechanism":"Arava works by inhibiting the enzyme Cytochrome P450 1A2, which is involved in the production of inflammatory chemicals in the body."},{"drug_id":"cortisone-acetate","indication_name":"Psoriasis with arthropathy","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Cortone","generic_name":"CORTISONE ACETATE","company_name":"","drug_phase":"marketed","molecular_target":"Corticosteroid-binding globulin","drug_class":"alpha-Adrenergic Agonist [EPC]","quality_score":29,"revenue":null,"mechanism":""},{"drug_id":"otezla","indication_name":"Psoriasis with arthropathy","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Otezla","company_name":"L.H. Kircik, M.D.","drug_phase":"marketed","molecular_target":"cAMP-specific 3',5'-cyclic phosphodiesterase 4A, cAMP-specific 3',5'-cyclic phosphodiesterase 4B, cAMP-specific 3',5'-cyclic phosphodiesterase 4C","drug_class":"","quality_score":20,"revenue":null,"mechanism":null}],"pipeline":[],"offLabel":[],"totalMarketed":35,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03573765","title":"Epidemiology and Outcomes of Upper Limb Surgery: Analysis of Routine Data","phase":"","overall_status":"COMPLETED","enrollment_count":8308821,"lead_sponsor_name":"University of Oxford","has_results":false},{"nct_id":"NCT05170321","title":"Analysis of Influencing Factors and Construction of Prediction Models of Artificial Joint Replacement in China","phase":"","overall_status":"UNKNOWN","enrollment_count":600000,"lead_sponsor_name":"Xiangya Hospital of Central South University","has_results":false},{"nct_id":"NCT07398742","title":"Incidence and Microbial Profiles of Periprosthetic Joint Infection After Total Knee Arthroplasty in Obese vs Non-Obese Patients","phase":"","overall_status":"COMPLETED","enrollment_count":101299,"lead_sponsor_name":"Bispebjerg Hospital","has_results":false},{"nct_id":"NCT05603728","title":"Exactech Shoulder Post Market Clinical Follow-up Study","phase":"","overall_status":"RECRUITING","enrollment_count":20000,"lead_sponsor_name":"Exactech","has_results":false},{"nct_id":"NCT06024161","title":"Weight Change and the Risk of Chronic Pain Following Hip and Knee Arthroplasties","phase":"","overall_status":"UNKNOWN","enrollment_count":6400,"lead_sponsor_name":"Bispebjerg Hospital","has_results":false},{"nct_id":"NCT06462885","title":"Living Alone is Predictive of Non-home Discharge Following Elective Total Hip Arthroplasty: a Matched-pairs Cohort Analysis","phase":"","overall_status":"COMPLETED","enrollment_count":5677,"lead_sponsor_name":"University of Virginia","has_results":false},{"nct_id":"NCT05575700","title":"Safety of Ibuprofen After Major Orthopaedic Surgeries","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":2904,"lead_sponsor_name":"Naestved Hospital","has_results":false},{"nct_id":"NCT03283878","title":"Antibiotic Prophylaxis in Patients Undergoing Elective Total Knee Arthroplasty- Multi-center Trial","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":1770,"lead_sponsor_name":"Duke University","has_results":false},{"nct_id":"NCT03744039","title":"Management of Diabetic Patients With Neuropathic Osteoarthropathy (Charcot Foot) : Descriptive Study in Diabetic-foot Centers","phase":"","overall_status":"COMPLETED","enrollment_count":1160,"lead_sponsor_name":"Centre Hospitalier Universitaire de Nīmes","has_results":false},{"nct_id":"NCT04123873","title":"Effect of Combinations of Paracetamol, Ibuprofen, and Dexamethasone on Patient-Controlled Morphine Consumption in the First 24 Hours After Total Hip Arthroplasty","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":1060,"lead_sponsor_name":"Naestved Hospital","has_results":false},{"nct_id":"NCT06120023","title":"Post-Market Clinical Follow Up for Total Knee Arthroplasty System Madison","phase":"","overall_status":"RECRUITING","enrollment_count":1000,"lead_sponsor_name":"Societe dEtude, de Recherche et de Fabrication","has_results":false},{"nct_id":"NCT04229368","title":"Effect of Vitamin D Status and Repletion on Postoperative Total Joint Arthroplasty Complications","phase":"NA","overall_status":"UNKNOWN","enrollment_count":900,"lead_sponsor_name":"Brigham and Women's Hospital","has_results":false},{"nct_id":"NCT03148951","title":"Effect of NLR and MPV on Early Postoperative Outcome in Lower Extremity Arthroplasty Operations","phase":"","overall_status":"COMPLETED","enrollment_count":754,"lead_sponsor_name":"Akdeniz University","has_results":false},{"nct_id":"NCT04137484","title":"Patient Blood Management Program in Total Hip or Total Knee Arthroplasty","phase":"","overall_status":"COMPLETED","enrollment_count":723,"lead_sponsor_name":"University Hospital, Montpellier","has_results":false},{"nct_id":"NCT03495232","title":"Persona Cohort Nordic Multicenter Study","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":700,"lead_sponsor_name":"Zimmer Biomet","has_results":false},{"nct_id":"NCT05649007","title":"Post-marketing Surveillance Study of the Saphir Stem in Primary Hip Surgery","phase":"","overall_status":"RECRUITING","enrollment_count":630,"lead_sponsor_name":"Gruppo Bioimpianti S.r.l.","has_results":false},{"nct_id":"NCT05647629","title":"Observational Study of the Development of Low Back Pain After Total Hip Arthroplasty.","phase":"","overall_status":"RECRUITING","enrollment_count":618,"lead_sponsor_name":"Universidad de Zaragoza","has_results":false},{"nct_id":"NCT06924567","title":"Radiographic Stability of Hip Prosthesis Prior to Revision Surgery","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":600,"lead_sponsor_name":"Georgios Tsikandylakis, MD PhD","has_results":false},{"nct_id":"NCT04883788","title":"The Impact of COVID-19 Pandemic on Hip and Knee Replacement","phase":"","overall_status":"COMPLETED","enrollment_count":600,"lead_sponsor_name":"Istituto Ortopedico Rizzoli","has_results":false},{"nct_id":"NCT05944380","title":"PENG Block for Total Hip Arthroplasty","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":556,"lead_sponsor_name":"Poznan University of Medical Sciences","has_results":false},{"nct_id":"NCT05338255","title":"Results of the Application of the Clinical Pathway of Intensified Recovery Surgery for Adults in the Processes of Total Knee and Hip Replacement at the Maz Hospital","phase":"","overall_status":"COMPLETED","enrollment_count":534,"lead_sponsor_name":"Universidad de Zaragoza","has_results":false},{"nct_id":"NCT06251349","title":"Comparative Analysis of Radiotherapeutic and Medical Procedures for the Prophylaxis of Heterotopic Ossifications","phase":"","overall_status":"COMPLETED","enrollment_count":512,"lead_sponsor_name":"University of Jena","has_results":false},{"nct_id":"NCT06511856","title":"FH ORTHO Shoulder Observatory","phase":"","overall_status":"RECRUITING","enrollment_count":500,"lead_sponsor_name":"FH ORTHO","has_results":false},{"nct_id":"NCT03975673","title":"Patient-Specific Techniques for Hip Replacement","phase":"NA","overall_status":"UNKNOWN","enrollment_count":460,"lead_sponsor_name":"Centre de l'arthrose, Paris","has_results":false},{"nct_id":"NCT06440863","title":"Postoperative BMI Changes and Functional Outcomes in Knee and Hip Arthroplasty","phase":"NA","overall_status":"COMPLETED","enrollment_count":459,"lead_sponsor_name":"Istanbul University - Cerrahpasa","has_results":false},{"nct_id":"NCT04014413","title":"Safety and Efficacy of Fecal Microbiota Transplantation","phase":"NA","overall_status":"RECRUITING","enrollment_count":450,"lead_sponsor_name":"Chinese University of Hong Kong","has_results":false},{"nct_id":"NCT06182059","title":"Persistent Post Surgical Pain After Total Knee Arthroplasty","phase":"NA","overall_status":"RECRUITING","enrollment_count":436,"lead_sponsor_name":"Policlinico di Monza SpA","has_results":false},{"nct_id":"NCT03282201","title":"A Survey on Blood Transfusions in Major Artrhoplasty Operations","phase":"","overall_status":"COMPLETED","enrollment_count":418,"lead_sponsor_name":"Diskapi Teaching and Research Hospital","has_results":false},{"nct_id":"NCT03364088","title":"Outcome After Total Knee Arthroplasty Under General or Spinal Anesthesia","phase":"NA","overall_status":"COMPLETED","enrollment_count":402,"lead_sponsor_name":"Riku Antero Palanne","has_results":false},{"nct_id":"NCT03647709","title":"Opioid-free Accelerated Recovery Total Knee Arthroplasty","phase":"","overall_status":"COMPLETED","enrollment_count":400,"lead_sponsor_name":"St. Elizabeth Medical Center, Utica, NY","has_results":true},{"nct_id":"NCT05638386","title":"Effect of Plugging the Registration Pin Tract in Robotic-assisted Knee Surgery","phase":"","overall_status":"COMPLETED","enrollment_count":384,"lead_sponsor_name":"Reinier Haga Orthopedisch Centrum","has_results":false},{"nct_id":"NCT03763448","title":"Infrapatellar Fat Pad Preservation Versus Resection on Clinical Outcomes After Total Knee Arthroplasty(IPAKA)","phase":"NA","overall_status":"COMPLETED","enrollment_count":377,"lead_sponsor_name":"Zhujiang Hospital","has_results":false},{"nct_id":"NCT05319223","title":"Patient Blood Management in Orthopedic Surgical Patients in Turkey","phase":"","overall_status":"UNKNOWN","enrollment_count":369,"lead_sponsor_name":"Prof. Serdar Gunaydin","has_results":false},{"nct_id":"NCT06086483","title":"Pain Management After Adductor Canal Block for Total Knee Arthroplasty","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":361,"lead_sponsor_name":"Poznan University of Medical Sciences","has_results":false},{"nct_id":"NCT03541798","title":"Comparison of Three Different Sitting Positions for Performing Combined Spinal-Epidural Anesthesia","phase":"NA","overall_status":"COMPLETED","enrollment_count":360,"lead_sponsor_name":"Diskapi Teaching and Research Hospital","has_results":false},{"nct_id":"NCT07494032","title":"Extended Oral Tranexamic Acid After Primary Total Knee Arthroplasty","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":350,"lead_sponsor_name":"NYU Langone Health","has_results":false},{"nct_id":"NCT03058380","title":"Stated-Preferences in Knee Arthroplasty","phase":"","overall_status":"COMPLETED","enrollment_count":348,"lead_sponsor_name":"Duke University","has_results":false},{"nct_id":"NCT06715709","title":"How Many Dexamethasone Doses Should Be Given Perioperatively?","phase":"PHASE4","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":339,"lead_sponsor_name":"Mayo Clinic","has_results":false},{"nct_id":"NCT04262908","title":"Socio-professional Categories and Return to Work After Hip or Knee Replacement Surgery","phase":"","overall_status":"UNKNOWN","enrollment_count":300,"lead_sponsor_name":"Groupe Hospitalier Diaconesses Croix Saint-Simon","has_results":false},{"nct_id":"NCT06124651","title":"Comparison of Cruciate Retaining and Posterior Stabilized Total Knee Arthroplasty","phase":"NA","overall_status":"COMPLETED","enrollment_count":300,"lead_sponsor_name":"Ewha Womans University","has_results":false},{"nct_id":"NCT05067543","title":"Perform Humeral System Study","phase":"","overall_status":"RECRUITING","enrollment_count":300,"lead_sponsor_name":"Stryker Trauma and Extremities","has_results":false},{"nct_id":"NCT06053060","title":"Evaluation of the Positioning of the Dynacup Cup \"One C\" Versus \"Standard Dynacup\"","phase":"NA","overall_status":"COMPLETED","enrollment_count":300,"lead_sponsor_name":"Groupe Hospitalier Diaconesses Croix Saint-Simon","has_results":false},{"nct_id":"NCT06832995","title":"Incidence and Risk Factors for Post-Anesthetic Morphine Titration in Recovery Room After Hip and Knee Arthroplasties","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":300,"lead_sponsor_name":"Hôpital Privé Sévigné","has_results":false},{"nct_id":"NCT05602753","title":"Smoking Cessation Study","phase":"","overall_status":"UNKNOWN","enrollment_count":300,"lead_sponsor_name":"McGill University Health Centre/Research Institute of the McGill University Health Centre","has_results":false},{"nct_id":"NCT05357378","title":"Safety and Effectiveness of the HIT Reverse HRS","phase":"NA","overall_status":"RECRUITING","enrollment_count":288,"lead_sponsor_name":"Hip Innovation Technology","has_results":false},{"nct_id":"NCT05295004","title":"The Effect of Mindfulness Training Before Primary Total Joint Arthroplasty on Sleep Quality","phase":"NA","overall_status":"UNKNOWN","enrollment_count":282,"lead_sponsor_name":"Colorado Joint Replacement","has_results":false},{"nct_id":"NCT04594564","title":"Squeaking in Ceramic-on-Ceramic Total Hip Arthroplasty Using Delta TT Cup","phase":"","overall_status":"COMPLETED","enrollment_count":270,"lead_sponsor_name":"Seoul National University Hospital","has_results":false},{"nct_id":"NCT04886570","title":"Clinical Follow-up of Hip Arthroplasty: A Cross-section and Longitudinal Study","phase":"","overall_status":"UNKNOWN","enrollment_count":260,"lead_sponsor_name":"Taipei Veterans General Hospital, Taiwan","has_results":false},{"nct_id":"NCT04262713","title":"Evaluation of Predictive Factors for Ruptures of Meije Duo ™ Size 1 and 2 Femoral Stems in Hip Replacement Surgery","phase":"NA","overall_status":"COMPLETED","enrollment_count":256,"lead_sponsor_name":"Groupe Hospitalier Diaconesses Croix Saint-Simon","has_results":false},{"nct_id":"NCT06257160","title":"Superiority Randomized Controlled Trial of Ultrasound-guided PENG Block Compared to Surgical Infiltration in the Analgesia of Posterior Total Hip Arthroplasty Surgery","phase":"NA","overall_status":"COMPLETED","enrollment_count":224,"lead_sponsor_name":"CHU de Reims","has_results":false}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}